Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrated PET/MR and PET/CT in Prostate Cancer
NCT06355843Suspended
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Apr 2022
- Primary completion
- Sep 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: Value of 68Ga-PSMA PET/MRI in the diagnosis and staging of primary prostate cancer at 28 months and Diagnostic efficacy of 68Ga-PSMA PET/MRI at 32 months. Started Apr 2022; status: suspended.
Beyond the preview
Go deeper on NCT06355843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06355843.